OverviewChartNewsTraderScreen

BVT Knock-Out GNMSF/  DE000VQ99CP3  /

Frankfurt Zert./VONT
8/1/2024  8:04:22 PM Chg.-0.170 Bid9:58:13 PM Ask9:58:13 PM Underlying Strike price Expiration date Option type
24.580EUR -0.69% -
Bid Size: -		 -
Ask Size: -		 Genmab A/S 3,812.38 DKK 12/31/2078 Put
GlobeNewswire 6/28 Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Re...
GlobeNewswire 6/27 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 6/24 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 6/1 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 5/29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 5/21 Genmab Completes Acquisition of ProfoundBio
GlobeNewswire 5/21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 5/17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 5/14 Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization...
GlobeNewswire 5/14 Immatics Announces First Quarter 2024 Financial Results and Business Update
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 5/2 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 4/30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...
GlobeNewswire 4/22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 4/7 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 4/3 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
GlobeNewswire 3/20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 3/11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 3/7 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 3/6 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 3/4 Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of ...
GlobeNewswire 2/14 Genmab Announces Initiation of Share Buy-Back Program
GlobeNewswire 2/14 Genmab Publishes 2023 Annual Report
GlobeNewswire 2/8 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...